Corresponding Authors: Lili Hong, MD, Department of Oncology, Tianjin Huanghe Hospital, Tianjin, People’s Republic of China (firstname.lastname@example.org); Tong Liu, MD, PhD, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China (email@example.com).
Published Online: April 25, 2022. doi:10.1001/jamainternmed.2022.1226
Conflict of Interest Disclosures: None were reported.
Additional Contributions: We thank Nan Zhang, MD, Second Hospital of Tianjin Medical University, and Gan-Xin Yan, PhD, Lankenau Medical Center, for their helpful comments. They were not compensated for their contributions.
BJ , Naidoo
J , Santomasso
et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. J Clin Oncol
. 2021;39(36):4073-4126. doi:10.1200/JCO.21.01440PubMedGoogle ScholarCrossref
B , Knilans
TK , eds. Chou’s Electrocardiography in Clinical Practice. 6th ed. W.B. Saunders; 2008.